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Comorbid chronic diseases, discordant impact on
mortality in older people: a 14-year longitudinal
population study
G E Caughey,1 E N Ramsay,2 A I Vitry,1 A L Gilbert,1 M A Luszcz,3 P Ryan,2
E E Roughead1
ABSTRACT
Objectives To determine the impact of comorbid chronic
diseases on mortality in older people.
Design Prospective cohort study (1992e2006).
Associations between numbers of chronic diseases or
mutually exclusive comorbid chronic diseases on
mortality over 14 years, by Cox proportional hazards
model adjusting for sociodemographic variables or
KaplaneMeier analyses, respectively.
Setting Population based, Australia.
Participants 2087 randomly selected participants aged
$65 years old, living in the community or institutions.
Main results Participants with 3e4 or $5 diseases
had a 25% (95% CI 1.05 to 1.5, p¼0.01) and 80%
(95% CI 1.5 to 2.2, p<0.0001) increased risk of
mortality, respectively, by comparison with no chronic
disease, after adjusting for age, sex and residential
status. When cardiovascular disease (CVD), mental
health problem or diabetes were comorbid with arthritis,
there was a trend towards increased survival (range
8.2e9.5 years) by comparison with CVD, mental health
problem or diabetes alone (survival 5.8e6.9 years). This
increase in survival with arthritis as a comorbidity was
negated when CVD and mental health problems or CVD
and diabetes were present in disease combinations
together.
Conclusion Older people with $3 chronic diseases
have increased risk of mortality, but discordant effects
on survival depend on specific disease combinations.
These results raise the hypothesis that patients who
have an increased likelihood of opportunity for care from
their physician are more likely to have comorbid diseases
detected and managed.
INTRODUCTION
The prevalence of multiple chronic diseases
(multimorbidity) is 65e80% in older people and is
projected to rise with the increasing older popula-
tion.1 2 Despite this, the majority of clinical prac-
tice and research to date has a single-disease-based
paradigm, which may not be suitable for older
patients with multiple morbidities.3e5 While
evidence-based guidelines can assist practitioners to
make appropriate treatment choices, relatively few
of these guidelines take into account patients with
multiple chronic conditions. As such, their appli-
cability to the population of older people has been
questioned.3 4 6 7
It is becoming increasingly evident that primary
caremust becomemore centred on thewhole patient
rather than on individual diseases.3 5 Knowledge
of the most prevalent morbidity combinations in
older people will help to facilitate the development
of appropriate guidelines for management and
coordination of care for these patients. Additionally,
an understanding of the impact of these combina-
tions of chronic diseases on mortality may further
help to highlight the importance of appropriate,
timely and comprehensive treatment strategies for
patients with particular chronic disease proﬁles.
Much of the research on multimorbidity has
focused on the prevalence of coexistent chronic
diseases,2 8e10 or the overall impact of multi-
morbidity on health. Multimorbidity is associated
with a decrease in quality of life, self-rated health
and functional status.11 12 It is also associated with
increased mortality, with two or more chronic
diseases resulting in a twofold or more increase in
mortality risk.11 13 14 However, the effects of
speciﬁc combinations of chronic diseases on health
outcomes, costs and quality of care is less well
studied, and as such there is a strong need for more
clinically relevant research if we are to provide
optimal care for patients with multiple chronic
diseases.15 A US study reported signiﬁcant differ-
ences in the age-adjusted 5-year mortality rate for
veterans with hypertension, depression and osteo-
arthritis of 4.2% compared to 34.6% for those with
hypertension, cancer and chronic obstructive
pulmonary disorder.14
The aim of this study is to determine the
impact of speciﬁc chronic disease combinations
and the effects of multimorbidity on mortality
over a 14-year period in older people ($65 years
old). This study will focus on those chronic
diseases that account for the majority of mortality
and burden of disease worldwide.16
METHODS
Study sample
The study sample included 2087 men and women,
aged 65 years and older, from the Australian
Longitudinal Study of Ageing, which has previ-
ously been described.17 Brieﬂy, it is a large
prospective population-based study of human
ageing. It began in 1992 with the primary sample
randomly selected from the South Australian
Electoral Roll, with subjects stratiﬁed by gender,
location and cohorts aged 65e69, 70e74, 75e79,
80e84 and 85 years or older. Older men were
oversampled to ensure sufﬁcient numbers for
longitudinal follow-up. Written informed consent
was obtained from all participants, and the study
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protocol was approved by the Flinders University. The
University of South Australia additionally approved the design
upon which this report is based.
Measurements
Chronic diseases
The prevalence of chronic diseases was assessed in face-to-face
interviews by asking participants with the aid of prompt cards
whether they had ever suffered from, or currently have, any of
the following chronic conditions: arthritis, osteoporosis, cancer
(including bladder, bowel, breast, colon, gynaecological,
leukaemia, lung, melanoma, prostate, rectal or other cancer),
diabetes, asthma, chronic bronchitis, angina, heart attack, heart
condition, stroke, small stroke (transient ischaemic attack),
hypertension, mental disorder, nervous breakdown, hiatus
hernia and gastrointestinal ulcer. The presence of depressive
symptoms was measured using the Centre for Epidemiological
Studies-Depression Scale,18 with a clinically relevant level of
depression deﬁned by a score of $16.
Individual chronic diseases were grouped where appropriate
into broader disease categories, including cardiovascular disease
(CVD) (angina, heart attack, heart condition, stroke, small
stroke), mental health problem (mental disorder, nervous
breakdown, depression), gastrointestinal disease (hiatus hernia,
gastrointestinal ulcer) and respiratory disorder (asthma, chronic
bronchitis).
Self-rated health and activities of daily living
The association between self-rated health or activities of daily
living at baseline and speciﬁc comorbid diseases was assessed.
Self-rated health provides a global assessment of the partici-
pant’s perception of overall health status. Participants were
asked, “In general how would you rate your present health?”
with ﬁve response categories (poor, fair, good, very good or
excellent).19 For the analyses of speciﬁc disease combinations,
the responses were grouped into two categories: (poor or fair)
(good, very good or excellent).
Physical impairment was assessed using the activities of daily
living that included eight self-care activities: bathing, personal
grooming, dressing, eating, using the toilet, going to a place
away from home, moving inside the house and transferring from
bed to chair. In this study, the responses were dichotomised into
no difﬁculty with any activity and difﬁculty with one or more
activities.
Mortality
The primary endpoint for this part of the study was all-cause
mortality. Survival data were obtained from death certiﬁcates
searched by the Epidemiology Branch of the Department of
Health in South Australia, and deaths were conﬁrmed by the
South Australian Births, Deaths and Marriages Registration
Ofﬁce, as described and validated previously.20 21 If no direct
match was made, the electoral roll was checked for name or
address changes or errors and for those whose deaths occurred in
another state or overseas. The date of death was supplied by
informants nominated by participants at baseline. For each
participant, time to event was calculated as the interval between
baseline interview date and the date of death or the date of
administrative censoring on 31 December 2006, whichever
occurred ﬁrst.
Statistical analyses
Baseline demographic and health characteristics were stratiﬁed
by number of chronic diseases. Comparisons were made
between those with 0, 1, 2, 3e4 and $5 chronic diseases using
Pearson c2 test for categorical variables and one-way ANOVA for
continuous variables. The association between the numbers of
chronic diseases and mortality was examined using Cox
proportional hazards models adjusting for age, sex and residen-
tial status. KaplaneMeier analyses were used to examine
mutually exclusive speciﬁc chronic diseases or combinations of
chronic diseases on mortality. Only those chronic disease
combinations with a prevalence of 0.5% or higher were included
in this analyses. All analyses were performed using SAS version
9.1 (SAS Institute, Inc).
RESULTS
Table 1 displays the baseline demographic and health charac-
teristics of participants, classiﬁed according to the number of
chronic diseases. Almost 90% of respondents reported having at
least one chronic disease, with 64% reporting two or more
chronic diseases (table 1). The age of respondents was similar
between the groups with differing numbers of chronic diseases,
with the average age ranging from 77.9 to 78.6 years old. Gender,
education level, income and marital status of participants were
also similar between the groups (table 1). Compared with
persons who had no chronic diseases, those with increasing
numbers of diseases were less likely to live within the commu-
nity, have poorer self-rated health and have difﬁculties with
more than one activity of daily living.
The overall prevalence of chronic diseases and disease group-
ings is reported in table 2. Fifty-four per cent of respondents
reported arthritis, with only 13% reporting arthritis as their only
condition. Similarly, while 36% reported having CVD, only 9%
reported CVD as their only condition (table 2). Table 2 also
shows the prevalence of speciﬁc chronic disease combinations.
Arthritis and CVD was the most common disease combination,
followed by arthritis together with hypertension or gastroin-
testinal disease or mental health problem. Almost 10% of the
study sample reported the presence of arthritis, CVD and
hypertension, and 3.6% reported this combination together with
gastrointestinal disease. Arthritis was the most common
comorbid disease, followed by CVD, gastrointestinal disease,
hypertension and mental health problem.
When considering single conditions, CVD or mental health
problem tended to have poorer self-rated health, by comparison
to those with no disease or other single diseases (table 3). An
increase in the prevalence of those reporting poor or fair self-
rated health was generally observed with the addition of
comorbidity to each of the index diseases. This was most
apparent in those with CVD or mental health problem (table 3).
For most index diseases, there was a trend to increased difﬁculty
with activities of daily living with the addition of comorbidity
(table 3). In general, when arthritis was present as a comor-
bidity, there was a reduced ability to perform activities of daily
living. This was most evident in those with mental health
problem (table 3).
A total of 1469 subjects died during the 14-year follow-up
period, representing 70.4% of the study population. Survival
analysis (adjusted for age, gender and residential aged care
status) demonstrated that with increasing numbers of chronic
diseases at baseline, there was a statistically signiﬁcant decrease
in survival (ﬁgure 1). The median survival time for older people
who had no chronic diseases at baseline was 10.4 years (95% CI
9.2 to 11.6) (ﬁgure 1). By comparison, the median survival
times of those with 1, 2, 3e4 and $5 chronic diseases was
10.1 years (95% CI 9.2 to 11.0), 9.6 years (95% CI 8.7 to 10.5),
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8.9 years (95% CI 7.9 to 9.9) and 6.4 years (95% CI 5.7 to 7.0),
respectively.
When considering those with only one disease, the presence of
CVD or mental health problem or diabetes was associated with
a minimum 33% reduction in survival by comparison to those
with no chronic disease or arthritis or gastrointestinal disease or
hypertension (table 4). Interestingly, the addition of arthritis as
a comorbidity with either CVD or mental health problem or
diabetes resulted in a trend towards an increase in survival
(table 4). For example, the median survival time of those with
a mental health problem only was 6.0 years (95% CI 3.9 to 11.9);
however, when arthritis was present, median survival time
increased to 9.5 years (95% CI 6.0 to 11.8) (table 4). However,
this increase in survival associated with arthritis was negated
when CVD and mental health problem were comorbid, or when
diabetes and CVD were comorbid in two, three or four disease
combinations (where applicable) (table 4). Thus, the simple
addition of another comorbid disease to speciﬁc diseases or
disease combinations did not necessarily result in an additive or
multiplicative effect on mortality.
DISCUSSION
In the present study, we found a high prevalence of multi-
morbidity, with almost two-thirds of the population of older
people reporting two or more chronic diseases. The presence of
three or more chronic diseases was associated with a 25%
increased risk of mortality over the 14-year study period, while
ﬁve or more chronic diseases was associated with an 80%
increased risk of mortality. Importantly, this study described
discordant effects of speciﬁc comorbid disease combinations on
mortality in older people. CVD and mental health problems
were highly prevalent comorbidities and were associated with
increased mortality. In contrast, diabetes, which was one of the
least common comorbid diseases, tended to have the greatest
effect on mortality when comorbid with CVD. Arthritis,
however, was the most prevalent comorbid disease but was
generally associated with longer survival times. This increased
survival associated with arthritis was negated when CVD and
mental health problem or CVD and diabetes were present in
diseases combinations together.
Despite the reported high prevalence of multimorbidity in
older people and the major impact of chronic diseases with
regard to their huge disease burden and associated costs, there
are comparatively few studies that have focused on the long-
term mortality (more than 5 years of follow-up) associated with
multiple chronic diseases. Our data agree with previous studies
of shorter duration that report that multimorbidity has a nega-
tive impact on mortality.11 13 22 In light of our ﬁndings regarding
the differing impacts of speciﬁc disease combinations on
mortality, an understanding that diabetes alone is associated











Overall prevalence % (95% CI) 12.7 (11.3 to 14.3) 23.3 (21.4 to 25.2) 23.9 (22.1 to 25.7) 27.6 (25.6 to 29.5) 12.6 (11.2 to 14.1)
Sex (% female) 51.9 47.9 48.4 48.7 53.1 0.59
Age, mean (SD) 78.6 (7.3) 78.3 (6.9) 77.9 (6.5) 78.1 (6.4) 78.6 (6.4) 0.015
Age groups (years, %) 0.009
65e69 9.4 6.8 6.0 6.0 5.3
70e74 24.8 26.5 28.7 25.9 27.4
75e79 18.1 24.6 27.4 27.9 22.1
80e84 26.7 19.1 18.0 20.8 23.9
85+ 20.9 23.1 19.9 19.5 21.2
Place of residence (%) <0.0001
Community 94.0 95.5 95.4 94.4 87.4
Institution 6.0 4.5 4.6 5.6 12.6
Education (age left school, %) 0.63
<14 years 19.1 14.8 15.6 16.8 16.7
$14 years 80.9 85.2 84.4 83.2 83.3
Income 0.65
#US$12000 36.3 35.1 35.8 34.2 38.2
US$12001e20000 43.8 43.6 43.8 47.2 44.3
US$20001e30000 12.5 10.3 11.5 11.3 11.8
>US$30000 7.5 11.0 8.9 7.3 5.7
Marital status 0.09
Never married 3.0 2.3 5.4 3.7 3.4
Married/de facto 65.1 66.7 62.7 67.6 64.9
Widowed 28.6 28.2 28.7 26.1 31.7
Divorced/separated 3.4 2.9 2.2 2.6 0
Self-rated health <0.0001
Excellent 19.3 15.5 7.8 3.8 1.5
Very good 43.4 37.4 30.7 22.3 8.4
Good 29.8 28.3 33.3 34.9 19.5
Fair 6.4 15.1 21.7 29.1 42.9
Poor 1.1 3.7 6.4 9.8 27.6
Activities of daily living <0.0001
No difficulties 90.6 90.0 84.9 76.3 65.3
More than 1 9.4 10.0 15.6 20.7 34.7
p Values were derived from Pearsons c2 test for association between the indicated variable and the number of chronic diseases for categorical variables or one-way ANOVA for continuous
variables.
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with an increase in mortality, but also that CVD associated with
diabetes results in a twofold increase in mortality,23 reinforces
the importance of effective management of diabetes and CVD
risk factors in the context of multimorbidity. In addition, mental
health problems, in particular depression, are often thought of as
a benign disease in terms of its effects on long-term health
outcomes, including mortality. However, it is becoming
increasingly evident that depression can have signiﬁcant impact
when comorbid with other chronic diseases. For example, when
depression is comorbid with diabetes, it results in an increase in
mortality by almost 40%,24 and when comorbid with CVD
results in an almost threefold increase in mortality.25 This study
highlights the need for greater awareness of the impact of
mental health problems on long-term outcomes when comorbid
with other chronic diseases. Ideally, this may then translate into
appropriate treatment strategies for comorbid mental health
problems.
We observed lower rates of mortality associated with arthritis,
similar to that observed in a previous study with a younger
cohort.22 When osteoarthritis was present as a comorbid
condition in people aged 55e64 years old, a 20e35% reduction
in 5-year mortality was observed.22 While several explanations
have been proposed for the association of arthritis with lower
mortality rates,22 importantly we hypothesise that opportunity
to receive care for speciﬁc diseases combinations is an important
factor affecting survival. It is the “symptomatic” diseases, such
as arthritis, that are more likely to result in those patients
presenting to their primary care physician for treatment. As
a consequence, it is these patients who will have a greater
likelihood of earlier detection of other diseases and will be
subsequently earlier managed. In contrast, patients with
a disease such as CVD, whose ﬁrst presentation is more
commonly an acute episode, would be less likely to have other
comorbid diseases detected and managed. In support of this,
a recent study reported that patients with more conditions
receive higher quality of care (an increased number of services
recommended to them by their providers) than patients with
fewer conditions,26 potentially by virtue of increased opportu-
nities for care. Further, in patients with diabetes, comorbidity,
regardless of whether it shares the same pathophysiological
mechanism, is proposed to increase a patient’s overall health
system use.27
In accord with previous results,11 multimorbidity was asso-
ciated with a decrease in self-rated health and ability to perform
activities of daily living. Our study additionally shows that self-
rated health is not dependent on the number of chronic diseases
but more on the speciﬁc comorbid disease combinations. CVD
and mental health problems were associated with poorer self-
rated health, alone and when comorbid with other chronic
diseases, and self-rated health decreased most when CVD and
mental health problem were comorbid with one another. The
effectiveness of self-rated health as a predictor of mortality in
older people is well recognised,28 and a recent meta-analysis of
22 cohort studies found that persons who reported “poor” self-
Table 2 Prevalence of chronic diseases or disease groupings and multimorbidity at baseline (n¼2087)
For 23 disease combinations, the most prevalent disease combinations are shown for each disease or disease grouping and if the prevalence levels of a disease combination is $10%; for 33
disease combinations, those with a prevalence $5% are shown; for 43 disease combinations, those with a prevalence $2% are shown.
*Disease grouping.
CVD, cardiovascular disease; GI, gastrointestinal; HT, hypertension; MHP, mental health problem.
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rated health had a twofold increased of mortality compared
with persons who reported “excellent” self-rated health.29 From
our study results, those chronic disease combinations that were
associated with poorer survival time in general were also those
disease combinations that resulted in poorer self-rated health.
Ideally, the results from this study need to be further vali-
dated in a larger cohort of older persons. We limited the
number of morbidities to include only chronic diseases, in
particular those that were highly prevalent and associated
with signiﬁcant disease burden in the population of older
people. These chronic diseases represent high-priority condi-
tions for healthcare worldwide,30 in addition to being
identiﬁed as Australian National Health Priorities.31 However,
by focusing on these “major” chronic diseases only, we may
have underestimated the prevalence of multimorbidity and the
impact of other chronic conditions that could have potentially
affected quality of life and daily functioning (for example
allergic rhinitis or vision problems), yet not necessarily
mortality.
The data included in this study were based predominantly
on patient self-report of chronic disease, apart from depression
that was measured using the Centre for Epidemiological
Studies-Depression Scale scale. While medical records are
generally considered the “gold standard” of clinical data
collection,32 33 self-report of medical conditions is an impor-
tant tool in epidemiology research and has been noted to be
more appropriate for study at a population level rather than
limited to just those individuals hospitalised or attending
general practice.34 In a recent Australian study, prevalence
results for most chronic diseases were similar when reported
from medical records by a general practitioner compared with
a population-based Australian National Health Survey that
uses self-report.35
Primary care physicians are the main providers of care for
patients with multimorbidity,36 and the chronic diseases
included in this study account for the majority of chronic
conditions managed at this level.37 Given that the majority of
older patients will present to their primary care physician with
multimorbidity, our results highlight the need for a greater
awareness for managing patients’ overall health status within
the context of multiple disease states rather than as a single
disease entity. Patterns of care for those with multiple chronic
diseases need to reﬂect a more patient-centred approach, inte-
grating the individual needs of patients and their speciﬁc disease
states. Patients with chronic diseases make daily decisions about
Table 3 Effect of specific chronic diseases or chronic disease
groupings on self-rated health and activities of daily living*
Chronic disease grouping (n)




No chronic disease (266) 7.9 (5.1 to 11.8) 9.4 (6.2 to 13.4)
Arthritis (172) 14.4 (9.6 to 18.3) 13.3 (8.7 to 19.1)
GI disease (42) 16.3 (9.2 to 25.3) 3.5 (1.0 to 9.8)
HT (85) 13.9 (5.3 to 17.9) 4.7 (5.7 to 15.8)
Arthritis+GI disease (67) 25.0 (15.5 to 36.6) 12.5 (5.9 to 22.4)
Arthritis+HT (85) 20.4 (12.6 to 30.3) 14.8 (8.1 to 23.9)
Arthritis+GI disease+HT (29) 29.0 (14.2 to 46.0) 9.7 (2.0 to 25.7)
Cancer (40) 20.0 (9.1 to 35.6) 7.5 (1.6 to 20.4)
Cancer+arthritis (31) 25.0 (11.5 to 43.4) 12.5 (3.5 to 28.9)
Respiratory disease (41) 24.7 (13.2 to 40.3) 2.3 (0.6 to 12.0)
Respiratory disease+arthritis (26) 35.7 (18.6 to 55.9) 10.7 (2.3 to 28.2)
CVD (83) 29.7 (22.0 to 40.7) 14.3 (7.6 to 23.6)
CVD+arthritis (78) 30.0 (20.3 to 41.3) 17.5 (9.9 to 27.6)
CVD+GI disease (22) 17.3 (5.0 to 38.7) 13.0 (2.8 to 33.6)
CVD+HT (40) 36.6 (22.2 to 53.1) 17.1 (7.2 to 32.0)
CVD+arthritis+GI disease (28) 50.0 (31.3 to 68.7) 30.0 (14.7 to 49.4)
CVD+arthritis+HT (51) 34.0 (21.8 to 41.8) 12.5 (5.2 to 24.1)
CVD+arthritis+GI disease+HT (16) 44.4 (21.5 to 69.2) 33.3 (16.4 to 47.6)
MHP (31) 32.3 (16.7 to 51.3) 16.1 (5.4 to 33.7)
MHP+arthritis (43) 46.5 (31.2 to 62.3) 25.6 (13.5 to 41.2)
MHP+arthritis+GI disease (16) 50.0 (31.3 to 68.7) 30.0 (14.7 to 49.4)
MHP+CVD (12) 61.6 (31.5 to 86.1) 15.4 (19.2 to 45.4)
MHP+CVD+arthritis (14) 60.0 (32.3 to 83.6) 53.3 (26.5 to 78.7)
MHP+CVD+arthritis+GI disease (19) 75.0 (50.9 to 91.3) 33.3 (6.4 to 47.6)
MHP+CVD+arthritis+HT (14) 64.3 (35.1 to 87.2) 28.6 (8.3 to 58.1)
Diabetes (20) 20.0 (5.7 to 43.6) 15.0 (3.2 to 37.9)
Diabetes+arthritis (16) 18.8 (4.4 to 45.6) 6.3 (1.6 to 30.2)
Diabetes+CVD+arthritis (14) 57.2 (28.9 to 82.3) 21.4 (4.7 to 50.7)
*Mutually exclusive specific diseases or disease combinations.
ADL, activities of daily living; CVD, cardiovascular disease; GI, gastrointestinal;
HT, hypertension; MHP, mental health problem; SRH, self-rated health.
Figure 1 Adjusted survival curves
classified according to number of chronic
diseases at baseline over 14 years
(adjusted for age, gender and residential
status).
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the management of their diseases,38 and patient self-manage-
ment is essential for effective chronic illness care and improved
patient outcomes.38 39 Multimorbidity can have profound
effects on a patient’s ability to self-manage their care. Similarly,
medication adherence may also pose signiﬁcant problems
for patients’ managing complex treatment regimens with
multimorbidity.
Given the prevalence and burden associated with the chronic
diseases examined in this study, our results have signiﬁcant
implications for the primary care physician in terms of the
awareness and formulation of management and care strategies
for multimorbid patients. Those disease combinations that are
the most prevalent, or those that have the greatest impact on
survival, should be targeted for the development of more
appropriate treatment strategies. While the management of
comorbid conditions needs to be included in future clinical
guidelines, treatment decisions must remain individualised,
incorporating evidence, clinical judgement and patient-speciﬁc
information and circumstance. At present, the quality of
healthcare for older persons with multiple chronic conditions is
suboptimal and uncoordinated.4 5 The development of appro-
priate and integrated processes of care for the multimorbid
person is among the most critical issues healthcare systems face
worldwide.
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